In a Q&A titled “Helping piece together the life sciences puzzle,” health care counsel Alison Fethke discusses critical systems and controls pharmaceutical and medical device manufacturers should consider when creating integrated global compliance programs that can be presented to the U.S. Department of Justice and Securities and Exchange Commission. The article was published in the Chicago Daily Law Bulletin on April 3, 2017.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find our more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.